I-Sep
Nantes
About I-Sep
i-SEP is a French Medtech specializing in auto-transfusion and the Patient Blood Management. i-SEP has developed a completely innovative technology for the separation of blood components. Our ambition is to become the first French start-up to market a self-transfusion system capable of recovering both red blood cells and platelets during hemorrhagic surgical procedures. i-SEP works in close collaboration with the surgical teams of reference with missions to improve the patient benefit, simplify the work of practitioners and help reduce hospital costs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $2.2M
- Last round: Series Unknown (Apr 2017)
- Website: i-sep.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/i-sep-161872 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.